Haemonetics CorporationHAENYSE
Loading
EV/EBITDA Over TimeContracting
Percentile Rank14
3Y CAGR-16.2%
5Y CAGR-11.1%
Year-over-Year Change
Enterprise value to EBITDA ratio
3Y CAGR
-16.2%/yr
vs -6.6%/yr prior
5Y CAGR
-11.1%/yr
Recent deceleration
Acceleration
-9.6pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 11.51 | -31.0% |
| 2024 | 16.68 | -10.2% |
| 2023 | 18.59 | -4.9% |
| 2022 | 19.55 | -42.0% |
| 2021 | 33.70 | +62.3% |
| 2020 | 20.77 | -16.6% |
| 2019 | 24.91 | -3.1% |
| 2018 | 25.70 | +39.9% |
| 2017 | 18.38 | +14.1% |
| 2016 | 16.11 | - |